Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Baseload Capital in connection with its issuance of MSEK 500 senior secured green bonds
Mandate

Vinge has advised Baseload Capital in connection with its issuance of MSEK 500 senior secured green bonds

March 27, 2019 Banking and Finance

Vinge has advised Baseload Capital Sweden AB (publ) in connection with its issuance of MSEK 500 senior secured green bonds under a framework of MSEK 1,500. 

The bonds have a tenor of four (4) years and carries an interest rate set to 3 months STIBOR plus 825 basis points. DNB Bank ASA, Filial Sverige acted as sole arranger and issuing agent. The bond proceeds will mainly be used for the development of geothermal power plants in accordance with the company’s green bond framework (which is aligned with the ICMA Green Bond Principles 2018).

Vinge’s team consisted of Louise Brorsson Salomon, Lionardo Ojeda and Pauline Lagerstrand.
 

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026